Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 10, 2016

Primary Completion Date

July 1, 2019

Study Completion Date

September 10, 2019

Conditions
Gastro Esophageal Reflux
Interventions
PROCEDURE

ARAT

After confirmation of GERD, participants will undergo to ablation with Hybrid-APC (ARAT). Participant will be admitted to hospital 24 hrs before procedure. Technique consist in ablation with hybrid-APC, submucosal injection of saline solution with methylene blue at 3-4 cm from 60-70% cardias and 1 cm esophageal. After procedure they will be kept on surveillance and will be followed-up with clinical, endoscopic, esophageal manometry and pHmetry up to 1 year after procedure.

Trial Locations (1)

06720

Centro Medico Nacional Siglo XXI, Hospital de Especialidades, Mexico City

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT03548298 - Antireflux Ablation Therapy (ARAT) for Gastroesophageal Reflux Treatment | Biotech Hunter | Biotech Hunter